Richard Scolyer is at the forefront of melanoma treatment and research, but a devastating cancer diagnosis of his own has made him the self-described "patient zero" in a new frontier of brain cancer treatment.
Since then, he and his colleagues have gone down a path of experimental treatment, and have given a National Press Club address, announcing they’ve “generated in 10 weeks discoveries that would normally take years”.
He was rushed to hospital and after a number of tests, Professor Scolyer was diagnosed with glioblastoma IDH wild-type, a cancer that’s considered incurable and usually fatal within six to nine months.
One of the first phone calls Professor Scolyer’s wife made from Poland was to his Melanoma Institute Australia co-medical director, Georgina Long.
Melanoma Institute Australia has been at the forefront of treatments like immunotherapy, that have drastically improved survival rates for the deadly skin cancer.
Rather than go down the usual treatment path for glioblastoma of surgery, radiotherapy and chemotherapy, they decided to try to treat Professor Scolyer in a similar way to their melanoma patients.
“Proving something that we’d already shown in melanoma, that there is no blood brain barrier and historically conceptualised, preventing the drugs from reaching the tumour,” Professor Long said.
The original article contains 705 words, the summary contains 170 words. Saved 76%. I’m a bot and I’m open source!
This is the best summary I could come up with:
Since then, he and his colleagues have gone down a path of experimental treatment, and have given a National Press Club address, announcing they’ve “generated in 10 weeks discoveries that would normally take years”.
He was rushed to hospital and after a number of tests, Professor Scolyer was diagnosed with glioblastoma IDH wild-type, a cancer that’s considered incurable and usually fatal within six to nine months.
One of the first phone calls Professor Scolyer’s wife made from Poland was to his Melanoma Institute Australia co-medical director, Georgina Long.
Melanoma Institute Australia has been at the forefront of treatments like immunotherapy, that have drastically improved survival rates for the deadly skin cancer.
Rather than go down the usual treatment path for glioblastoma of surgery, radiotherapy and chemotherapy, they decided to try to treat Professor Scolyer in a similar way to their melanoma patients.
“Proving something that we’d already shown in melanoma, that there is no blood brain barrier and historically conceptualised, preventing the drugs from reaching the tumour,” Professor Long said.
The original article contains 705 words, the summary contains 170 words. Saved 76%. I’m a bot and I’m open source!